NO144457C - Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydro-1,4-pyridiner - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydro-1,4-pyridinerInfo
- Publication number
- NO144457C NO144457C NO762790A NO762790A NO144457C NO 144457 C NO144457 C NO 144457C NO 762790 A NO762790 A NO 762790A NO 762790 A NO762790 A NO 762790A NO 144457 C NO144457 C NO 144457C
- Authority
- NO
- Norway
- Prior art keywords
- pyridines
- preparation
- therapeutic active
- analogy procedure
- dihydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB33501/75A GB1511694A (en) | 1975-08-12 | 1975-08-12 | Pyridine derivatives |
| GB4518875 | 1975-10-31 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO762790L NO762790L (no) | 1977-02-15 |
| NO144457B NO144457B (no) | 1981-05-25 |
| NO144457C true NO144457C (no) | 1981-09-02 |
Family
ID=26261898
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO762790A NO144457C (no) | 1975-08-12 | 1976-08-11 | Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydro-1,4-pyridiner |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4096270A (no) |
| JP (1) | JPS5223081A (no) |
| AR (1) | AR209672A1 (no) |
| AT (1) | AT351025B (no) |
| AU (1) | AU504839B2 (no) |
| CA (1) | CA1079284A (no) |
| CH (1) | CH612678A5 (no) |
| CS (1) | CS194774B2 (no) |
| DD (1) | DD126696A5 (no) |
| DE (1) | DE2635916A1 (no) |
| DK (1) | DK362676A (no) |
| ES (1) | ES450582A1 (no) |
| FR (1) | FR2320750A1 (no) |
| MX (1) | MX3464E (no) |
| NL (1) | NL7608989A (no) |
| NO (1) | NO144457C (no) |
| PT (1) | PT65456B (no) |
| SE (1) | SE7608959L (no) |
| SU (1) | SU1007556A3 (no) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH639659A5 (de) * | 1978-12-18 | 1983-11-30 | Sandoz Ag | Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung. |
| DE2738153A1 (de) * | 1977-08-24 | 1979-03-08 | Bayer Ag | 2-pyridyl-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| DE2949464A1 (de) * | 1978-12-18 | 1980-06-26 | Sandoz Ag | Benzoxadiazole und benzothiadiazole, ihre herstellung und verwendung |
| US4497808A (en) * | 1981-12-30 | 1985-02-05 | Ciba-Geigy Corporation | N-Oxide compounds useful in the treatment of cardiovascular ailments |
| DE3207982A1 (de) * | 1982-03-05 | 1983-09-08 | Bayer Ag, 5090 Leverkusen | Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln |
| US4414213A (en) * | 1982-03-22 | 1983-11-08 | Mead Johnson & Company | Dihydropyridyl cyclic imidate esters and their pharmaceutical use |
| US4771057A (en) * | 1986-02-03 | 1988-09-13 | University Of Alberta | Reduced pyridyl derivatives with cardiovascular regulating properties |
| DE4236707A1 (de) * | 1992-10-30 | 1994-05-05 | Bayer Ag | 4-Heterocyclyl substituierte Dihydropyridine |
| US6001857A (en) * | 1992-10-30 | 1999-12-14 | Bayer Aktiengesellschaft | Heterocyclyl substituted dihydropyridines |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1670824C3 (de) * | 1967-03-20 | 1978-08-03 | Bayer Ag, 5090 Leverkusen | 1,4-Dihydropyridin-33-dicarbonsäurealkylester |
| DE1813436C3 (de) * | 1968-12-07 | 1979-01-11 | Bayer Ag, 5090 Leverkusen | N-Substituierte 2,6-Dimethyl-l,4dihydropyridine |
| DE1923990C3 (de) * | 1969-05-10 | 1978-11-23 | Bayer Ag | Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern |
| DE2003146A1 (de) * | 1970-01-24 | 1971-07-29 | Bayer Ag | Neue 1,4-Dihydropyridinderivate |
| DE2005116C3 (de) * | 1970-02-05 | 1980-02-14 | Bayer Ag, 5090 Leverkusen | Symmetrische 1,4-Dihydropyridin-3,5-dicarbonsäureester |
| DE2117573C3 (de) * | 1971-04-10 | 1978-07-27 | Bayer Ag, 5090 Leverkusen | Verfahren zur Herstellung von unsymmetrischen l,4-Dihydropyridin-3,5dicarbonsäureestern, sowie ihre Verwendung als Arzneimittel |
| DE2117571C3 (de) * | 1971-04-10 | 1979-10-11 | Bayer Ag, 5090 Leverkusen | Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel |
| DE2210672C3 (de) * | 1972-03-06 | 1980-03-20 | Bayer Ag, 5090 Leverkusen | N-substituierte unsymmetrische 1 ^-Dihydropyridin-S^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel |
| DE2218644C3 (de) * | 1972-04-18 | 1982-08-19 | Bayer Ag, 5090 Leverkusen | Basische Ester von 1,4-Dihydropyridinen, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel |
| DE2248150A1 (de) * | 1972-09-30 | 1974-04-04 | Bayer Ag | Dihydropyridinpolyester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
-
1976
- 1976-07-21 FR FR7622285A patent/FR2320750A1/fr active Granted
- 1976-08-02 AT AT568776A patent/AT351025B/de not_active IP Right Cessation
- 1976-08-04 MX MX002128U patent/MX3464E/es unknown
- 1976-08-04 AU AU16569/76A patent/AU504839B2/en not_active Expired
- 1976-08-05 US US05/711,862 patent/US4096270A/en not_active Expired - Lifetime
- 1976-08-05 CH CH1001576A patent/CH612678A5/xx not_active IP Right Cessation
- 1976-08-06 AR AR264249A patent/AR209672A1/es active
- 1976-08-06 CA CA258,591A patent/CA1079284A/en not_active Expired
- 1976-08-09 ES ES450582A patent/ES450582A1/es not_active Expired
- 1976-08-09 PT PT65456A patent/PT65456B/pt unknown
- 1976-08-10 DD DD194263A patent/DD126696A5/xx unknown
- 1976-08-10 DE DE19762635916 patent/DE2635916A1/de not_active Withdrawn
- 1976-08-11 DK DK362676A patent/DK362676A/da not_active Application Discontinuation
- 1976-08-11 CS CS765241A patent/CS194774B2/cs unknown
- 1976-08-11 SE SE7608959A patent/SE7608959L/xx not_active Application Discontinuation
- 1976-08-11 NO NO762790A patent/NO144457C/no unknown
- 1976-08-11 JP JP51095887A patent/JPS5223081A/ja active Granted
- 1976-08-12 SU SU762386167A patent/SU1007556A3/ru active
- 1976-08-12 NL NL7608989A patent/NL7608989A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CH612678A5 (no) | 1979-08-15 |
| NO144457B (no) | 1981-05-25 |
| FR2320750A1 (fr) | 1977-03-11 |
| MX3464E (es) | 1980-12-09 |
| NL7608989A (nl) | 1977-02-15 |
| SE7608959L (sv) | 1977-02-13 |
| AU504839B2 (en) | 1979-11-01 |
| US4096270A (en) | 1978-06-20 |
| DK362676A (da) | 1977-02-13 |
| JPS5223081A (en) | 1977-02-21 |
| DD126696A5 (no) | 1977-08-03 |
| NO762790L (no) | 1977-02-15 |
| DE2635916A1 (de) | 1977-02-24 |
| ATA568776A (de) | 1978-12-15 |
| PT65456B (fr) | 1978-02-10 |
| SU1007556A3 (ru) | 1983-03-23 |
| CA1079284A (en) | 1980-06-10 |
| ES450582A1 (es) | 1977-11-16 |
| FR2320750B1 (no) | 1979-09-28 |
| AR209672A1 (es) | 1977-05-13 |
| CS194774B2 (en) | 1979-12-31 |
| AU1656976A (en) | 1978-02-09 |
| JPS5422986B2 (no) | 1979-08-10 |
| PT65456A (fr) | 1976-09-01 |
| AT351025B (de) | 1979-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO145199C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive nortropinestere. | |
| NO147243C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater | |
| NO152899C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive glycerolderivater. | |
| NO149102C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive trans-4-fenyl-1,2,3,4-tetrahydro-1-naftalenamin-derivater | |
| NO151411C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater | |
| NO141800C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner. | |
| NO143460C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner. | |
| NO145379C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamider. | |
| NO156787C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater. | |
| NO146396C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidinderivater. | |
| NO150884C (no) | Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive imidazotiazolderivater | |
| NO143223C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,3-dimetyl-1h-pyrazol(3,4b)kinoliner | |
| NO146359C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive cyproheptadinderivater | |
| NO145198C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktivt 1,2-benzisotia-zolinon-3 | |
| NO154013C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive sesquiterpenderivater. | |
| NO142838C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater | |
| NO144457C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydro-1,4-pyridiner | |
| NO143064C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksyalkylxantiner | |
| NO148291C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive basisk substituerte teofyllinderivater | |
| NO148488C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive acyl-benzimidazol-2-derivater | |
| NO145163C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive antitumorglykosider | |
| NO151660C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater. | |
| NO145238C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrokarbostyril-derivater | |
| NO143903C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-fluorpyrimidin-4-on-derivater | |
| NO142669C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive, heterocykliske forbindelser |